ImmunityBio, Inc. — Director's Dealing 2016

Mar 18, 2016

SEC Form 3/A — Form 3/A

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2015-07-27

Reporting Person: Kusserow Richard (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246861	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.2161	2024-03-17	Common Stock (123439)		Direct

Footnotes

F1: This Form 3/A is filed to amend the Form 3 filed July 27, 2015 to correct the number of shares beneficially owned.

F2: Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option is March 17, 2014. The option originally covered 200,000 pre 1.8515 for 1 forward split shares.